Convenzis - Event ~ Neurofibromatosis European Meeting

Neurofibromatosis European Meeting - Manchester

Abstract Submissions for this Conference are now closed.

20th Neurofibromatosis Meeting Manchester 10-11 October 2022

The 20th European Neurofibromatosis Meeting will be held in Manchester UK in October 2022 as a face to face conference. Whilst virtual conferences have led to a new way of working collaboratively internationally, these have somewhat stifled new collaborations as we have missed out on meeting socially together, as well as being able to talk face to face around posters. The Manchester conference will be organised as a face to face conference, however, if the pandemic continues to challenge us we will convert to a hybrid conference enabling those who are not ready for face to face meetings to have access to the full programme. This will be the 20th European Neurofibromatosis Conference representing over 30 years of NF conferences in Europe. The last conference was held in Rotterdam as a virtual conference in 2020 and previous conferences included the global Paris conference in 2018, the 2016 conference in Padua,2014 in Barcelona with the 15th European NF meeting being held in Istanbul. This 2022 conference will be the second time that Manchester has hosted the European NF Conference. Manchester has a world-leading reputation in neurofibromatosis research and is one of just two highly specialised services for NF1 in England, as well as the lead centre for the four centres NF2 highly specialised service set up in 2010. NF research began in the late 1980s in Manchester with Manchester producing the first management consensus guidelines at Old Trafford in 2004. Manchester has a rich history of clinical, epidemiological and molecular research on NF1, NF2 and Schwannomatosis. We trust that the Manchester conference will be an opportunity to bring us all together again to foster new research collaborations and to update ourselves on the most advanced research on neurofibromatosis. We look forward to welcoming you to Manchester.

At Convenzis we pride ourselves on our ability to develop, manage, and host both virtual and physical events for the public and commercial sectors.

Our physical events offer a unique opportunity to meet with key sector stakeholders in an informal and relaxed atmosphere, this provides an ideal chance to discuss strategic change and learn from some of the most well-respected public sector professionals in the country, all while soaking up the lovely atmosphere our venues and audience provide.

Neurofibromatosis European Meeting – Manchester

Organising Committee:

Dr. Grace Vassallo
Consultant Paediatric Neurologist and Clinical Lead HSS Complex NF1 Service, Manchester University NHS Foundation Trust

Prof. Gareth Evans
Professor in Medical genetics and Cancer Epidemiology, University of Manchester, UK

Mrs. Judith Eelloo
Lead Nurse HSS Complex NF1 Service, Manchester University NHS Foundation Trust

Scientific Committee:

Prof. Gareth Evans
Professor in Medical genetics and Cancer Epidemiology, University of Manchester, UK

Prof Ian Kamaly
Professor in Paediatric Neurosurgery Manchester University Hospitals NHS Foundation Trust

Dr. Shruti Garg
Consultant in Child and Adolescent Psychiatry and Clinical Research Fellow at the Institute of Brain, Behaviour and Mental Health, University of Manchester, UK

Prof. Stavros Stivaros
Professor Paediatric Neuroradiology and Translational Imaging. University of Manchester.

Dr. Emma Burkitt-Wright
Consultant Clinical Geneticist St. Mary Genomic Centre for Medicine Manchester University Hospitals

Prof Michel Kalamarides
Professor and Director of Neurosurgery at Pitie-Salpetrire Hospital

Prof Scott Plotkin
Harvard Professor of Neurology

Prof R Ferner
Professor of Neurology Guy`s and St. Thomas` Foundation Trust and National Lead for the HSS Complex NF1 service in UK

Prof Marco Giovannini
Department of Head and Neck Surgery - David Geffen School of Medicine at University of California Los Angeles

Prof Eric Legius
Human Genetics at the University of Leuven Belgium

Prof Juha Petonen
Cancer Research Unit and institute of Biomedicine University of Turku Finland

Prof Ignacio Blanco
Professor Germans Trias Hospital Barcelona Spain

Prof Pierre Wolkenstein
Professor of Dermatology and Head of the Department of Dermatology Hopital Henri-Mondor, Paris, France

Prof J P Kilday
Professor of Neuroncology - Royal Manchester Children`s Hospital

Dr. R. Oostenbrink
General Paediatrician Erasmus MC Rotterdam

Dr. Eva Trevisson
Geneticist University of Padova Italy

Speakers

David Geffen

University of California Los Angeles

Dr Grace Vassallo

Manchester University NHS Foundation Trust

Consultant Paediatric Neurologist and Clinical Lead HSS Complex NF1 Service

Dr. Shruti Garg

The Institute of Brain, Behaviour and Mental Health, University of Manchester, UK

Consultant in Child and Adolescent Psychiatry and Clinical Research Fellow

Gilles Atlan

NF2 BioSolutions UK & Europe

Vice President

Prof Michel Kalamarides

Pitie-Salpetrire Hospital

Professor and Director of Neurosurgery

Prof Eric Legius

University of Leuven Belgium

Professor of Human Genetics

Prof Gareth Evans

University of Manchester UK

Professor in Medical Genetics and Cancer Epidemiology Clinical Lead Manchester HSS NF2 Service

Prof Juha Petonen

University of Turka Finland

Cancer Research Unit and institute of Biomedicine

Prof Marco Giovannini

University of California Los Angeles

Professor of Neck and Head Surgery

Prof Rosalie Ferner

Guy's and St Thomas' Foundation Trust and HSS Complex NF1 Service in the UK

Professor of Neurology/National Lead

Prof Scott Plotkin

Harvard

Professor of Neurobiology

Prof Stavros Stivaros

University of Manchester UK

Professor Paediatric Neuroradiology and Translational Imaging

Prof. Andy King

Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Manchester Co-Director, Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre Northern Care Alliance NHS Group, University

Professor of Neurosurgery